Use

The MI-Heart Ceramides test is used to evaluate the risk of major adverse cardiovascular events within the next 1 to 5 years. Plasma ceramides are predictors of myocardial infarction, coronary revascularization, acute coronary syndrome hospitalization, and mortality within 5 years. The risk conferred by plasma ceramides is independent of common cholesterol levels and inflammatory markers, and they can be reduced through diet, exercise, and certain medications. This test is therefore useful in identifying individuals at elevated risk who may benefit from preventive strategies.